PCSK9 and type 2 diabetes mellitus: The strength of the correlation between plasma PCSK9 and NT-proBNP was likely greater in patients affected by type 2 diabetes mellitus (T2DM) (r = −0.483; p = 0.006) compared to non-diabetic patients (r = −0.235; p = 0.012).